Genomic analysis of tumor samples from 1113 PM patients revealed mutations in HP genes (such as PTCH1 and SUFU), though these mutations were rare (PTCH1 at 1.2%, SUFU at 0.8%) [226]. Here, PTCH1 is linked to neoplasm.